Seroprevalence of hepatitis C virus infection and evaluation of serum aminotransferase levels among haemodialysis patients in Izmir, Turkey

Journal of International Medical Research

Volumn 33, Issue 6, 2005, Pages 641-646

  Olut, A I ^a   Ozsakarya, F ^a   Dilek, M ^b  

^a SSK Tepecik Teaching Hospital   (Turkey)

^b SSK Izmir Hospital   (Turkey)

Author keywords

Haemodialysis; Hepatitis C virus; Serum aminotransferases; Viraemia

Indexed keywords

AMINOTRANSFERASE; VIRUS RNA;

ADULT; AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; HEMODIALYSIS PATIENT; HEPATITIS C; HUMAN; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; PREDICTION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; SEROPREVALENCE; TURKEY (REPUBLIC); VIREMIA;

EID: 29444454503     PISSN: 03000605     EISSN: None     Source Type: Journal    
DOI: 10.1177/147323000503300605     Document Type: Article

References (13)

1. Braumann KM, Nonnast-Daniel B, Boning D, Bocker A, Fret U: Improved physical performance after treatment of renal anemia with recombinant human erythropoietin. Nephron 1991; 58: 129-134.
2. Jadoul M, Poignet JL, Geddes C, Locatelli F, Medin C, Krajewska M, et al: The changing epidemiology of hepatitis C virus (HCV) infection in haemodialysis: European multicentre study. Nephrol Dial Transplant 2004; 19: 904-909.
3. Schneeberger PM, Keur I, van Loon AM, Mortier D, de Coul KO, van Haperen AV, et al: The prevalence and incidence of hepatitis C virus infections among dialysis patients in the Netherlands: a nationwide prospective study. J Infect Dis 2000; 182: 1291-1299.
4. Othman B, Monem F: Prevalence of antibodies to hepatitis C virus among hemodialysis patients in Damascus, Syria. Infection 2001; 29: 262-265.
5. Bdour S: Hepatitis C virus infection in Jordanian haemodialysis units: serological diagnosis and genotyping. J Med Microbiol 2002; 51: 700-704.
6. Shobokshi OA, Serebour FE, Al-Drees AZ, Mitwalli AH, Qahtani A, Skakni LI: Hepatitis C virus seroprevalence rate among Saudis. Saudi Med J 2003, 24 (Suppl 2): S81-S86.
7. Mistik A, Balik I: Epidemiological analysis of viral hepatitis in Turkey. In: 6th National Congress of Viral Hepatitis, Congress Book (Tekeli E, Balik I, eds). Ankara: VHSD Publishing, 2003; pp10-55.
8. Fabrizi F, Lunghi G, Andrulli S, Pagliari B, Mangano S, Faranna P, et al: Influence of hepatitis C virus (HCV) viraemia upon serum aminotransferase activity in chronic dialysis patients. Nephrol Dial Transplant 1997; 12: 1394-1398.
9. Fabrizi F, Martin P, Dixit V, Brezina M, Cole MJ, Gerosa S, et al: Quantitative assessment of HCV load in chronic hemodialysis patients: a cross-sectional survey. Nephron 1998; 80: 428-433.
10. Sayiner AA, Zeytinoglu A, Ozkahya M, Erensoy S, Ozacar T, Ok E, et al: HCV infection in haemodialysis, and CAPD patients. Nephrol Dial Transplant 1999; 14: 256-257.
11. Hoofnagle JH: Hepatitis C: the clinical spectrum of disease. Hepatology 1997; 26 (Suppl 1): 15S-20S.
12. Guh JY, Lai YH, Yang CY, Chen SC, Chuang WL, Hsu TC, et al: Impact of decreased serum transaminase levels on the evaluation of viral hepatitis in hemodialysis patients. Nephron 1995; 69: 459-465.
13. Espinosa M, Martin-Malo A, Alvarez de Lara MA, Soriano S, Aljama P: High ALT levels predict viremia in anti-HCV-positive HD patients if a modified normal range of ALT is applied. Clin Nephrol 2000; 54: 151-156.